Annals of Internal Medicine· 2017Q1· Guideline
Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians
- 690citations
- Q1SCImago
- 2017year
Short summary
Clinicians should offer bisphosphonates (alendronate, risedronate, zoledronic acid) or denosumab to women with osteoporosis to reduce hip and vertebral fracture risk, and bisphosphonates to men with clinically recognized osteoporosis for vertebral fracture risk.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Orthopedics and Sports Medicine
Orthopedics and Sports MedicineMedicine